Form 4: ACHV Officer Jerry Wan Granted 70,300 Stock Options
Insider Transaction Report
ACHIEVE LIFE SCIENCES, INC. Principal Accounting Officer Jerry Wan was granted 70,300 stock options with an exercise price of $4.36, vesting over four years.
Summary
- Jerry Wan, Principal Accounting Officer of ACHIEVE LIFE SCIENCES, INC. (ACHV), was granted 70,300 stock options.
- The stock options have an exercise price of $4.36 per share.
- The options will vest as to 1/4 of the total award on January 28, 2026, and thereafter in substantially equal monthly installments over 36 months.
- Vesting is contingent upon Jerry Wan's continued provision of service to the Issuer on each vesting date.
- The options expire on January 28, 2036.
- The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a routine disclosure of executive compensation, reflecting standard practice for aligning management incentives with company performance. It is neither significantly positive nor negative for the company's immediate outlook.
Positives
- The grant of stock options aligns the Principal Accounting Officer's financial interests with the long-term performance and shareholder value of ACHIEVE LIFE SCIENCES, INC.
- Equity compensation is a standard practice for retaining and incentivizing key executives.
Future Outlook
The vesting schedule of the stock options, extending over four years, indicates an expectation of continued service from the Principal Accounting Officer and a long-term incentive structure tied to future company performance.
Industry Context
StockSavvy.ai notes that equity grants, such as stock options, are a common and widely accepted form of executive compensation across various industries. These grants are designed to align the interests of management with those of shareholders by providing a direct financial incentive for long-term company growth and value creation.
Comparison to Industry Standards
- The grant of stock options to a Principal Accounting Officer is a standard practice in corporate compensation, comparable to similar equity incentive programs at companies like Pfizer Inc. or Moderna, Inc., which frequently use stock options and restricted stock units to reward and retain key executives.
- The four-year vesting schedule is typical for executive equity grants, aiming to ensure long-term commitment and performance, similar to vesting periods observed in technology companies such as Microsoft Corp. or Apple Inc.
Related Party Transactions
- Grant of 70,300 stock options to Jerry Wan, Principal Accounting Officer, by ACHIEVE LIFE SCIENCES, INC. This is a standard compensation arrangement between an executive and the company.
Stakeholder Impact
- Shareholders: Potential future dilution if options are exercised, but also increased alignment of executive incentives with long-term shareholder value.
- Management (Jerry Wan): Receives equity compensation, aligning personal financial interests with company performance and retention.
Next Steps
- Continued vesting of the stock options according to the specified schedule, subject to the reporting person's ongoing service.
- Potential exercise of vested options by Jerry Wan prior to their expiration date.
Key Dates
| Date | Description |
|---|---|
| 01/28/2025 | Date of earliest transaction reported, likely the establishment or effective date of the 10b5-1 plan. |
| 01/30/2025 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed. |
| 01/28/2026 | Transaction date for the stock option grant and the first vesting date for 1/4 of the total award. |
| 01/28/2036 | Expiration date of the granted stock options. |
Keywords
ACHIEVE LIFE SCIENCES, ACHV, Stock Option, Insider Transaction, Executive Compensation, Jerry Wan, Equity Grant, Form 4, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.